Adverse Drug Reaction Classification System

Pharmaceutical Information
Drug Name Nicotine
Drug ID BADD_D01564
Description Nicotine is highly toxic alkaloid. It is the prototypical agonist at nicotinic cholinergic receptors where it dramatically stimulates neurons and ultimately blocks synaptic transmission. Nicotine is also important medically because of its presence in tobacco smoke.
Indications and Usage For the relief of nicotine withdrawal symptoms and as an aid to smoking cessation.
Marketing Status approved
ATC Code N07BA01
DrugBank ID DB00184
KEGG ID D03365
MeSH ID D009538
PubChem ID 89594
TTD Drug ID D0T8GD
NDC Product Code 17205-601; 58316-010; 11673-195; 11673-879; 37808-900; 37808-948; 43598-447; 59450-003; 59779-443; 70000-0115; 0536-1107; 70677-0030; 52922-001; 58316-009; 75877-0002; 11822-3627; 11822-4975; 21130-820; 37808-533; 37808-658; 43598-448; 49035-195; 55910-313; 66715-9802; 66715-9805; 66715-9806; 70000-0114; 28663-009; 58316-006; 11673-727; 11673-881; 37808-682; 0135-0196; 37808-711; 37808-739; 49035-196; 53329-192; 59450-002; 60429-443; 60429-445; 62011-0351; 63868-734; 70677-0032; 60429-444; 0363-0455; 0363-0457; 66715-9804; 68016-288; 28663-010; 58316-011; 11822-4973; 37808-753; 43598-446; 0009-5401; 50090-1148; 53329-193; 68016-289; 0536-1108; 58316-008; 29485-5271; 50090-2860; 63981-124; 66715-9803; 68196-194; 0536-1106; 61252-3005; 50090-1697; 59450-001; 63981-190; 70677-0031; 0135-0194; 0135-0195; 49035-782; 49348-788; 50090-2837; 59779-445; 62011-0350; 63868-735; 66715-9801; 68016-290; 69842-828; 50392-101; 55742-003; 11673-971; 11822-4974; 37808-707; 37808-849; 50090-6383; 55741-449; 59779-448; 0363-0451; 62011-0349; 81870-001; 11673-269; 11673-424; 21130-269; 43598-445; 53329-191; 69842-605; 70000-0113; 58316-007; 11673-194; 11673-196; 29485-5270; 37808-383; 37808-911; 49035-194; 0009-5400
UNII 6M3C89ZY6R
Synonyms Nicotine | Nicotine Bitartrate | Nicotine Tartrate
Chemical Information
Molecular Formula C10H14N2
CAS Registry Number 54-11-5; 22083-74-5
SMILES CN1CCCC1C2=CN=CC=C2
Chemical Structure
ADRs Induced by Drug
*The priority for ADR severity classification is based on FAERS assessment, followed by the most severe level in CTCAE rating. If neither is available, it will be displayed as 'Not available'.
**The 'Not Available' level is hidden by default and can be restored by clicking on the legend twice..
ADR Term ADReCS ID ADR Frequency (FAERS) ADR Severity Grade (FAERS) ADR Severity Grade (CTCAE)
Uterine contractions abnormal21.07.03.003; 18.07.02.0020.000940%Not Available
Abnormal behaviour19.01.01.0010.002006%Not Available
Complication of pregnancy18.02.02.0030.000940%Not Available
Respiratory disorder neonatal22.11.01.002; 18.04.09.0020.001254%Not Available
Ill-defined disorder08.01.03.0490.001692%Not Available
Lip and/or oral cavity cancer07.21.07.001; 16.13.07.0010.000627%Not Available
Mitral valve disease02.07.01.0030.000627%
Salivary gland disorder07.06.02.0010.002131%Not Available
Facial spasm17.04.03.0100.000627%Not Available
Cystitis noninfective20.03.02.001--
Application site burn12.07.01.038; 08.02.01.038; 23.03.11.0130.004889%Not Available
Application site erosion23.07.03.011; 12.07.01.021; 08.02.01.021--Not Available
Oral herpes11.05.02.005; 07.05.07.002--Not Available
Pharyngeal disorder22.04.05.0070.002131%Not Available
Low birth weight baby18.04.02.0030.003761%Not Available
Type 1 diabetes mellitus14.06.01.010; 10.04.08.007; 05.06.01.0100.000940%Not Available
Oral disorder07.05.01.0050.002319%Not Available
Brain injury19.07.03.007; 17.11.01.0030.000627%Not Available
Oropharyngeal pain22.12.03.016; 07.05.05.0040.003698%
Tobacco poisoning12.03.01.054--Not Available
Foetal growth restriction18.03.01.0020.001881%
Substance-induced psychotic disorder19.03.01.007; 12.03.01.053--Not Available
Application site hypoaesthesia17.02.06.027; 12.07.01.045; 08.02.01.045--Not Available
Foetal heart rate deceleration abnormality18.03.02.012; 02.03.02.0220.000627%Not Available
Cardiovascular symptom02.11.04.002; 24.03.02.025--Not Available
Stenosis08.01.03.0600.000940%Not Available
Enamel anomaly07.09.02.0030.000627%Not Available
Large for dates baby18.04.02.0040.000627%Not Available
Neonatal respiratory distress syndrome22.11.02.010; 18.04.10.0030.000627%Not Available
Shoulder dystocia18.03.04.0020.000627%Not Available
The 13th Page    First    Pre   13 14    Next   Last    Total 14 Pages
ADReCS-Target
Drug Name ADR Term Target
Tip:  Drug Name  ADR Term  Protein  Variation  Gene